Browsing Tag
STAMPEDE trial
1 post
Game-changer for prostate cancer: Veracyte’s test predicts who will benefit from chemo
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, has announced compelling new data from the phase 3…